35
Views
0
CrossRef citations to date
0
Altmetric
Miscellaneous

Novel piperazine and piperidine compounds for schizophrenia

Pages 737-740 | Published online: 25 Feb 2005

Bibliography

  • WADENBERG ML: Serotonergic mechanisms in neuroleptic-induced catalepsy in the rat. Neurosci. Biobehav. Rev. (1996) 20(2):325–339.
  • ••Review of a series of experiments aimed at elucidating theinteraction between dopamine and serotonin receptors in the rat.
  • BROEKKAMP CLE, OOSTERLOO SK, BERENDSEN HHG,VAN DELFT AML: Effect of metergoline, fenfluramine, and 8-01I-DPAT on catalepsy induced by haloperidol or morphine. Naunyn-Schmiedeberg's Arch. Pharmacol. (1988) 388:191–195.
  • MCMILLEN BA, SCOTT SM, DAVANZO EA: Reversal ofneuroleptic-induced catalepsy by novel aryl-piperazine amdolytic drugs. J. Pharm. Pharmacol. (1988) 40:885–887.
  • ICHIKAWA J, KUROKI T, KITCHEN MT, MELTZER HY RN-8-011-DPAT, a 5-HT1A receptor agonist, inhibits amphetamine-induced dopamine release in rat striatum and nucleus accumbens. Eur. J. Pharmacol (1995) 287:179–184.
  • VAN DER HEYDEN JAM, BRADFORD LD: A rapidly ac-quired one-way conditioned avoidance procedure in rats as a primary screening test for antipsychotics: in-fluence of shock intensity on avoidance performance. Behav. Brain Res. (1988), 31: 61–67.
  • VAN DER POEL AM, NOACH EJK, MICZEK KA: Temporal patterning of ultrasonic distress calls in the adult rat: effects of morphine and benzodiazepines. Psychophar-macology (1989) 97:147–148.
  • VAN HEST A, VAN DRIMMELEN M, OLIVIER B: Flesinoxan shows antidepressent activity in a DRL 71-s screen. Psychopharmacology (1992) 107:474–479.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.